Control of norovirus infection
- PMID: 30346315
- DOI: 10.1097/MOG.0000000000000491
Control of norovirus infection
Abstract
Purpose of review: The purpose of the review is to provide an update on control measures for norovirus (NoV), which is the most commonly implicated pathogen in acute gastroenteritis and outbreaks, causing major disruption in nurseries, schools, hospitals and care homes.
Recent findings: Important developments include the discovery that virus particles, previously considered to be the infectious unit, also occur in clusters, which appear to be more virulent than individual virus particles; a working culture system using human stem-cell derived enteroids; promising results from early phase clinical trials of candidate NoV vaccines, which appear to be safe and immunogenic; chronic NoV affects patients with primary and secondary immune deficiencies. Although several treatments have been used none are supported by well designed clinical trials; infection control procedures are effective if properly implemented.
Summary: NoV remains an important cause of morbidity and mortality. Although there are exciting developments on the vaccine front, the mainstay of control remains good hand hygiene, adherence to infection control procedures and limiting contamination of food, water and the wider environment. Once vaccines are available there will be important decisions to be made about how best to implement them.
Similar articles
-
Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis.Expert Rev Vaccines. 2013 Feb;12(2):155-67. doi: 10.1586/erv.12.145. Expert Rev Vaccines. 2013. PMID: 23414407 Review.
-
Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.Vaccine. 2018 Jan 25;36(4):484-490. doi: 10.1016/j.vaccine.2017.12.009. Epub 2017 Dec 13. Vaccine. 2018. PMID: 29246474
-
How to prevent the spread of norovirus.Nurs Times. 2011 Jan 18-24;107(2):15-7. Nurs Times. 2011. PMID: 21366008
-
Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor Binding.Viral Immunol. 2016 Jun;29(5):315-9. doi: 10.1089/vim.2015.0141. Epub 2016 May 2. Viral Immunol. 2016. PMID: 27135874
-
Norovirus Vaccine: Priorities for Future Research and Development.Front Immunol. 2020 Jul 7;11:1383. doi: 10.3389/fimmu.2020.01383. eCollection 2020. Front Immunol. 2020. PMID: 32733458 Free PMC article. Review.
Cited by
-
Differences in epidemic spread patterns of norovirus and influenza seasons of Germany: an application of optical flow analysis in epidemiology.Sci Rep. 2020 Aug 24;10(1):14125. doi: 10.1038/s41598-020-70973-4. Sci Rep. 2020. PMID: 32839522 Free PMC article.
-
Reduced norovirus epidemic follows increased sales of hand hygiene products in Japan, 2020-2021.Environ Health Prev Med. 2023;28:18. doi: 10.1265/ehpm.22-00155. Environ Health Prev Med. 2023. PMID: 36878577 Free PMC article.
-
Prevalence of noroviruses in children hospitalized for acute gastroenteritis in Hohhot, China, 2012-2017.BMC Infect Dis. 2019 Jul 9;19(1):595. doi: 10.1186/s12879-019-4230-x. BMC Infect Dis. 2019. PMID: 31288749 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials